Validation of automatic MRI hippocampal subfield segmentation by histopathological evaluation in patients with temporal lobe epilepsy.


Journal

Seizure
ISSN: 1532-2688
Titre abrégé: Seizure
Pays: England
ID NLM: 9306979

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 16 12 2020
revised: 09 03 2021
accepted: 11 03 2021
pubmed: 23 3 2021
medline: 13 7 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

The present study validates the results of automated hippocampal subfield segmentation with histopathology in epilepsy patients undergoing epilepsy surgery. We performed an automated hippocampal subfield segmentation on presurgical three-dimensional, T1-weighted magnetization Prepared Rapid Acquisition of Gradient Echoes Magnetic Resonance Imaging (MRI) data of 25 patients with unilateral mesial temporal lobe epilepsy due to hippocampal sclerosis (HS), using Freesurfer Version 6.0. The resulting volumes of cornu ammonis (CA) subfields CA1, CA2/3, CA4 and the dentate gyrus (DG) were compared to the histopathological cell count. We found a significant correlation between histopathology in subregion CA2 and automated segmentation of subregion CA1 (p = 0.0062), CA2/3 (p = 0.004), CA4 (p = 0.0062) and the DG (p = 0.0054), between histopathology in CA3 and automated segmentation of CA1 (p = 0.0132), CA2/3 (p = 0.0004), CA4 (p = 0.0032) and the DG (p = 0.0037), as well as between histopathology in the DG and automated segmentation of CA1 (p = 0.0115), CA2/3 (p < 0.0001), CA4 (p < 0.0001) and the DG (p = 0.0001). The histopathological finding of HS type 1 could correctly be classified in all cases on MRI. The present study shows significant correlations between histopathological evaluation and results of the automated segmentation of the hippocampus, thereby validating the automated segmentation method. As the differential involvement of different hippocampal subfields may be associated with clinical parameters and the outcome after epilepsy surgery, the automated segmentation is also promising for prognostic purposes.

Identifiants

pubmed: 33752160
pii: S1059-1311(21)00080-7
doi: 10.1016/j.seizure.2021.03.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-102

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Katja Menzler (K)

Epilepsy Center Hessen, Philipps-University Marburg, Department of Neurology, Baldingerstrasse, 35043, Marburg, Germany. Electronic address: hattemer@med.uni-marburg.de.

Hajo M Hamer (HM)

Epilepsy Center, University Hospital Erlangen, Erlangen, Germany.

Peter Mross (P)

Epilepsy Center Hessen, Philipps-University Marburg, Department of Neurology, Baldingerstrasse, 35043, Marburg, Germany.

Felix Rosenow (F)

Epilepsy Center Hessen, Philipps-University Marburg, Department of Neurology, Baldingerstrasse, 35043, Marburg, Germany; Center for Personalized Translational Epilepsy Research (CePTER) Consortium, Germany; Department of Neurology, Goethe University, Frankfurt/Main, Germany.

Ralf Deichmann (R)

Center for Personalized Translational Epilepsy Research (CePTER) Consortium, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.

Marlies Wagner (M)

Center for Personalized Translational Epilepsy Research (CePTER) Consortium, Germany; Department of Neuroradiology, Goethe University, Frankfurt/Main, Germany.

René-Maxime Gracien (RM)

Center for Personalized Translational Epilepsy Research (CePTER) Consortium, Germany; Department of Neurology, Goethe University, Frankfurt/Main, Germany; Brain Imaging Center, Goethe University, Frankfurt/Main, Germany.

Arnd Doerfler (A)

Department of Neuroradiology, University Hospital Erlangen, Erlangen, Germany.

Ingmar Bluemcke (I)

Institute of Neuropathology, University Hospital Erlangen, Erlangen, Germany.

Roland Coras (R)

Institute of Neuropathology, University Hospital Erlangen, Erlangen, Germany.

Marcus Belke (M)

Epilepsy Center Hessen, Philipps-University Marburg, Department of Neurology, Baldingerstrasse, 35043, Marburg, Germany; Center for Personalized Translational Epilepsy Research (CePTER) Consortium, Germany.

Susanne Knake (S)

Epilepsy Center Hessen, Philipps-University Marburg, Department of Neurology, Baldingerstrasse, 35043, Marburg, Germany; Center for Personalized Translational Epilepsy Research (CePTER) Consortium, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH